Exosomes: Stand-alone therapy or complement?

Exosomes: Stand-alone therapy or complement?

Continue reading →

Biotech M&A Strong Year Ahead in 2023

Biotech M&A Strong Year Ahead in 2023

Continue reading →

Cancer testing backlog 2023 – biotech rescue?

Cancer testing backlog 2023 – biotech rescue?

Continue reading →

Will Monkeypox trigger a similar C19 scenario?

Will Monkeypox trigger a similar C19 scenario?

Continue reading →

Will smaller biotech companies challenge or replace the current cohort of Big Pharma?

Will smaller biotech companies challenge or replace the current cohort of Big Pharma?

The Financial Times released an article on 14 August 2020 highlighting the significant increase in healthcare IPOs of companies that are working towards a Covid-19 vaccine. According to Martin Steinbach, Head of EY’s IPO and listing services EMEIA, “2020’s initial...

Continue reading →

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

In 2016 a synthetic alternative (rFC) to horseshoe crab blood, used in bacterial infection detection for injectable procedures, was licensed. And yet horseshoe crabs are both threatened with extinction and in line for preservation due to Covid-19 and its...

Continue reading →

Breakthrough studies on monoclonal antibodies

Breakthrough studies on monoclonal antibodies

Researchers at Vanderbilt University Medical Centre (VUMC), based in Amsterdam, have recently published optimistic results from monoclonal antibody preclinical trials in Nature Medicine that could potentially be a breakthrough in the search for both a curative for the Covid-19...

Continue reading →

Hospital margins are down – is selling your health data a solution

Hospital margins are down – is selling your health data a solution

A framework allowing a more sensible approach to health data collection In our previous blog we outlined the pressure on hospital margins and the entire hospital business model as a direct result of Covid-19. One solution is the sale by...

Continue reading →